EFFECTS OF SGLT-2 INHIBITORS ON 24 H AMBP IN PATIENTS WITH TYPE 2 DIABETIC AND HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Wang, Qiongying [1 ]
Tian, Li [1 ]
Yu, Jing [1 ]
Bai, Feng [1 ]
机构：
[1] Lanzhou Univ Second Hosp, Lanzhou, Peoples R China
来源：
JOURNAL OF HYPERTENSION | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PS-C30-11
引用
收藏
页码：E466 / E466
页数：1
相关论文
共 50 条
  • [21] Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis
    Pinto, Lana C.
    Rados, Dimitris, V
    Remonti, Luciana R.
    Viana, Marina V.
    Leitao, Cristiane B.
    Gross, Jorge L.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (01): : 68 - 76
  • [22] Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis
    Tsai, Wen-Hsuan
    Chuang, Shih-Ming
    Liu, Sung-Chen
    Lee, Chun-Chuan
    Chien, Ming-Nan
    Leung, Ching-Hsiang
    Liu, Shu-Jung
    Shih, Hong-Mou
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [23] Dose-ranging effects of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis
    Pinto, L. C.
    Rados, D. R.
    Retnonti, L. R.
    Viana, M. V.
    Leitao, C. B.
    Gross, J. L.
    DIABETOLOGIA, 2018, 61 : S313 - S313
  • [24] Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis
    Wen-Hsuan Tsai
    Shih-Ming Chuang
    Sung-Chen Liu
    Chun-Chuan Lee
    Ming-Nan Chien
    Ching-Hsiang Leung
    Shu-Jung Liu
    Hong-Mou Shih
    Scientific Reports, 11
  • [25] Cardiovascular Outcomes with SGLT-2 inhibitors in patients with heart failure with or without type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
    Singh, Awadhesh Kumar
    Singh, Ritu
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (01) : 351 - 359
  • [26] ASSOCIATION OF SGLT2 INHIBITORS WITH STROKE IN PATIENTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Mi, D.
    Pan, P.
    Chen, S.
    Chen, S.
    Peng, F.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 88 - 88
  • [27] Cardiovascular outcomes of SGLT-2 inhibitors' subtypes in type 2 diabetes; an updated systematic review and meta-analysis of randomized controlled trials
    Ebrahimi, Pouya
    Soleimani, Hamidreza
    Mahalleh, Mehrdad
    Farisi, Pegah
    Taheri, Maryam
    Ramezani, Pedram
    Soltani, Parnian
    Nazari, Roozbeh
    Senobari, Nahid
    Mousavinezhad, Seyedeh Maryam
    Payab, Moloud
    Gooshvar, Mehrdad
    Zadeh, Amin Zaki
    Hosseini, Kaveh
    Ebrahimpur, Mahbube
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2025, 24 (01)
  • [28] SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: A systematic review and meta-analysis
    Guo, Man
    Ding, Jingya
    Li, Jingsong
    Wang, Jiying
    Zhang, Ting
    Liu, Cuiping
    Huang, Wei
    Long, Yang
    Gao, Chenlin
    Xu, Yong
    DIABETES OBESITY & METABOLISM, 2018, 20 (08): : 1977 - 1982
  • [29] EFFECT OF SGLT-2 INHIBITORS ON THE RISK FOR ANGINA IN PATIENTS WITH OR WITHOUT TYPE 2 DIABETES MELLITUS: A META-ANALYSIS
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Toumpourleka, Maria
    Boulmpou, Aristi
    Siskos, Fotios
    Koutsampasopoulos, Konstantinos
    Petidis, Konstantinos
    Kassimis, George
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E164 - E164
  • [30] Comparative efficacy of once-weekly semaglutide and SGLT-2 inhibitors in type 2 diabetic patients inadequately controlled with metformin monotherapy: a systematic literature review and network meta-analysis
    Sharma, Rohini
    Wilkinson, Lars
    Vrazic, Hrvoje
    Popoff, Evan
    Lopes, Sandra
    Kanters, Steve
    Druyts, Eric
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (09) : 1595 - 1603
12345